BRAF and neoplasm: TERT promoter mutations have been found to be associated with the presence of the BRAF-V600E mutations: the coexistence of BRAF-V600E and TERT mutation has been demonstrated to define a particularly aggressive group of thyroid tumors and in particular with tumor recurrence and mortality [60].